BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25845930)

  • 1. Patient outcomes according to adherence to treatment guidelines for rhythm control of atrial fibrillation.
    Qin D; Leef G; Alam MB; Rattan R; Munir MB; Patel D; Khattak F; Vaghasia N; Adelstein E; Jain SK; Saba S
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25845930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation).
    Barnett AS; Kim S; Fonarow GC; Thomas LE; Reiffel JA; Allen LA; Freeman JV; Naccarelli G; Mahaffey KW; Go AS; Kowey PR; Ansell JE; Gersh BJ; Hylek EM; Peterson ED; Piccini JP
    Circ Arrhythm Electrophysiol; 2017 Nov; 10(11):. PubMed ID: 29141842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study.
    Proietti M; Nobili A; Raparelli V; Napoleone L; Mannucci PM; Lip GY;
    Clin Res Cardiol; 2016 Nov; 105(11):912-920. PubMed ID: 27245329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study.
    Gulizia MM; Cemin R; Colivicchi F; De Luca L; Di Lenarda A; Boriani G; Di Pasquale G; Nardi F; Scherillo M; Lucci D; Fabbri G; Maggioni AP;
    Europace; 2019 Feb; 21(2):230-238. PubMed ID: 30060174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality risk of long-term amiodarone therapy for atrial fibrillation patients without structural heart disease.
    Qin D; Leef G; Alam MB; Rattan R; Munir MB; Patel D; Khattak F; Adelstein E; Jain SK; Saba S
    Cardiol J; 2015; 22(6):622-9. PubMed ID: 26412606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate use of antiarrhythmic drugs in paroxysmal and persistent atrial fibrillation in a large contemporary international survey: insights from RealiseAF.
    Chiang CE; Goethals M; O'Neill JO; Naditch-Brûlé L; Brette S; Gamra H; Zharinov O; Steg PG;
    Europace; 2013 Dec; 15(12):1733-40. PubMed ID: 23858023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists: Antithrombotic Agents in Atrial Fibrillation (ATA-AF) survey.
    Berisso MZ; Fabbri G; Gonzini L; Caruso D; Fontanella A; Pellegrini F; Silvestri N; Vincenti A; Mathieu G; Di Pasquale G;
    J Cardiovasc Med (Hagerstown); 2014 Aug; 15(8):626-35. PubMed ID: 24978662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).
    Lip GY; Laroche C; Ioachim PM; Rasmussen LH; Vitali-Serdoz L; Petrescu L; Darabantiu D; Crijns HJ; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP; Boriani G
    Eur Heart J; 2014 Dec; 35(47):3365-76. PubMed ID: 25176940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.
    Schreiber D; Rostock T; Fröhlich M; Sultan A; Servatius H; Hoffmann BA; Lüker J; Berner I; Schäffer B; Wegscheider K; Lezius S; Willems S; Steven D
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):308-17. PubMed ID: 25744570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic drug therapy for atrial fibrillation: are the guidelines guiding clinical practice?
    Reiffel JA; Naccarelli GV
    Clin Cardiol; 2006 Mar; 29(3):97-102. PubMed ID: 16596830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines-Atrial Fibrillation Registry.
    Field ME; Holmes DN; Page RL; Fonarow GC; Matsouaka RA; Turakhia MP; Lewis WR; Piccini JP;
    Circ Arrhythm Electrophysiol; 2021 Feb; 14(2):e008961. PubMed ID: 33419385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial.
    Zhang XD; Gu J; Jiang WF; Zhao L; Zhou L; Wang YL; Liu YG; Liu X
    Eur Heart J; 2014 May; 35(20):1327-34. PubMed ID: 24497338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
    Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C;
    Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.
    Lewis WR; Piccini JP; Turakhia MP; Curtis AB; Fang M; Suter RE; Page RL; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):770-7. PubMed ID: 25185244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world.
    Meiltz A; Zimmermann M; Urban P; Bloch A;
    Europace; 2008 Jun; 10(6):674-80. PubMed ID: 18403385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation practice patterns among cardiac electrophysiologists and cardiologists.
    Teme T; Goldberger JJ
    Cardiol J; 2014; 21(3):293-8. PubMed ID: 23799561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
    Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM
    Card Electrophysiol Rev; 2003 Sep; 7(3):201-7. PubMed ID: 14739713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.